home / stock / halb / halb news


HALB News and Press, Tykhe Corp From 04/18/22

Stock Information

Company Name: Tykhe Corp
Stock Symbol: HALB
Market: OTC
Website: halberdcorporation.com

Menu

HALB HALB Quote HALB Short HALB News HALB Articles HALB Message Board
Get HALB Alerts

News, Short Squeeze, Breakout and More Instantly...

HALB - Halberd Eliminates E. Coli in 20 Minutes Vs. 7-10 Days with Conventional Antibiotics

Jackson Center, Pennsylvania--(Newsfile Corp. - April 18, 2022) - Halberd Corporation (OTC PINK: HALB) demonstrated the efficacy of its patented extracorporeal methodology for treatment and eradication of disease states. The latest success was again extracorporeal elimination of E. coli bacter...

HALB - Halberd Eliminates E. Coli in 20 Minutes vs. 7-10 Days with Conventional Antibiotics

JACKSON CENTER, PA / ACCESSWIRE / April 18, 2022 / Halberd Corporation (OTC PINK: HALB ) demonstrated the efficacy of its patented extracorporeal methodology for treatment and eradication of disease states. The latest success was again extracorporeal elimination of E. coli bacteria from cere...

HALB - Halberd Entering the Medical Metaverse(TM)

JACKSON CENTER, PA / ACCESSWIRE / April 11, 2022 / Halberd Corporation (OTC PINK:HALB) announces plans to enter the Metaverse by the creation of non-fungible tokens (NFT's) to monetize certain intellectual properties of the company including but not limited to patents, patents pending, tra...

HALB - Halberd Entering the Medical Metaverse

Jackson Center, Pennsylvania--(Newsfile Corp. - April 11, 2022) - Halberd Corporation (OTC PINK: HALB) announces plans to enter the Metaverse by the creation of non-fungible tokens (NFT's) to monetize certain intellectual properties of the company including but not limited to patents, patents ...

HALB - Halberd Continues In-Vitro Successes With Elimination of Protein Linked to Depression

Jackson Center, Pennsylvania--(Newsfile Corp. - April 4, 2022) - Halberd Corporation (OTC Pink: HALB) demonstrated the extracorporeal elimination of C-Reactive Protein from cerebral spinal fluid (CSF) by exposure to tuned laser light, in vitro. Halberd, encouraged by its recent success in elim...

HALB - Infectious Disease Specialist Will Guide Halberd's Extracorporeal Elimination of Disease Antigens in Animals and Then Humans

Jackson Center, Pennsylvania--(Newsfile Corp. - March 16, 2022) - Halberd Corporation (OTC Pink: HALB) announces its entry into the next stage of research. To guide it, having successfully eliminated the Top 10 Target Antigens associated with neurodegenerative diseases in vitro, Halberd is ple...

HALB - Halberd Expands Its Technical Expertise with the Addition of Microbiology Professor

JACKSON CENTER, PA / ACCESSWIRE / March 8, 2022 / Halberd Corporation (OTC PINK:HALB ) is pleased to announce Youngstown State University's (YSU) Dr. Chester R. Cooper has joined its technical team. Dr. Cooper currently holds the position of Professor, Department of Biological Sciences, at ...

HALB - Halberd Expands Its Technical Expertise With the Addition of Microbiology Professor

Jackson Center, Pennsylvania--(Newsfile Corp. - March 8, 2022) - Halberd Corporation (OTC PINK: HALB) is pleased to announce Youngstown State University's (YSU) Dr. Chester R. Cooper has joined its technical team. Dr. Cooper currently holds the position of Professor, Department of Biological S...

HALB - Halberd's COVID-19 Antibody is the Only One In Competitive Tests to Bind to Omicron Variant

Outperforms Approved COVID Antibodies Jackson Center, Pennsylvania--(Newsfile Corp. - March 1, 2022) - Halberd Corporation's (OTC Pink: HALB) previously developed SARS-CoV-2 antibody demonstrated superior binding capability to the SARS-CoV-2 Omicron variant disease antigen. The Halberd antibo...

HALB - Halberd Medical Breakthrough for the Treatment of Neurodegenerative Diseases Affecting 36 Million Americans Annually

JACKSON CENTER, PA / ACCESSWIRE / February 22, 2022 / Halberd Corporation (OTC PINK:HALB) has made a medical breakthrough in the treatment of neurodegenerative diseases. With the successful elimination of glutamate from cerebral spinal fluid (CSF), Halberd has demonstrated the capability t...

Previous 10 Next 10